Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2025-04-24 00:00:00 ET · period of report 2025-04-23 · accession 0000950170-25-057996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-04-24 | 2025-04-23 | RLAY | Patel Sanjiv | Pres, CEO, Dir | S - Sale | $2.97 | -61.4K | 840.3K | -7% | -$182.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-23 | S | D | 18,653 | $2.97 | 821,667 | D | — | — | (F3) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 41,558 shares of RSUs on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F4) Includes 410,560 shares underlying RSUs. |
| 2 | Common | Common Stock | 2025-04-23 | S | D | 42,769 | $2.97 | 840,320 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 95,295 shares of restricted stock units ("RSUs") on April 22, 2025. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 452,118 shares underlying RSUs. |